DEFB116
gene geneOn this page
Also known as DEFB-16
Summary
DEFB116 (defensin beta 116, HGNC:18097) is a protein-coding gene on chromosome 20q11.21, encoding Beta-defensin 116 (Q30KQ4). Has antibacterial activity.
Defensins form a family of antimicrobial and cytotoxic peptides made by neutrophils. Defensins are short, processed peptide molecules that are classified by structure into three groups: alpha-defensins, beta-defensins and theta-defensins. All beta-defensin genes are densely clustered in four to five syntenic chromosomal regions.
Source: NCBI Gene 245930 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 22 total
- MANE Select transcript:
NM_001037731
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:18097 |
| Approved symbol | DEFB116 |
| Name | defensin beta 116 |
| Location | 20q11.21 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | DEFB-16 |
| Ensembl gene | ENSG00000215545 |
| Ensembl biotype | protein_coding |
| Entrez | 245930 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000400549
RefSeq mRNA: 1 — MANE Select: NM_001037731
NM_001037731
CCDS: CCDS42860
Canonical transcript exons
ENST00000400549 — 2 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001543449 | 31303212 | 31303453 |
| ENSE00001543450 | 31308519 | 31308585 |
Expression profiles
Bgee: expression breadth broad, 17 present calls, max score 37.20.
Top tissues by expression
91 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 37.20 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| monocyte | CL:0000576 | 30.26 | gold quality |
| urinary bladder | UBERON:0001255 | 30.03 | silver quality |
| leukocyte | CL:0000738 | 30.02 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.04 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| liver | UBERON:0002107 | 28.04 | gold quality |
| uterine cervix | UBERON:0000002 | 27.94 | gold quality |
| ectocervix | UBERON:0012249 | 27.74 | silver quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| tonsil | UBERON:0002372 | 27.05 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| gall bladder | UBERON:0002110 | 25.98 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 25.89 | gold quality |
| blood | UBERON:0000178 | 25.85 | silver quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| endocervix | UBERON:0000458 | 24.90 | gold quality |
| primary visual cortex | UBERON:0002436 | 24.61 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.81 |
Regulation
Is transcription factor: no
Literature-anchored findings (GeneRIF, showing 1)
- The encoded protein is thought to display antimicrobial activity. (PMID:16033865)
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Defb29 | ENSMUSG00000044249 |
| rattus_norvegicus | Defb29 | ENSRNOG00000023195 |
Paralogs (19): DEFB127 (ENSG00000088782), DEFB129 (ENSG00000125903), DEFB118 (ENSG00000131068), DEFB104A (ENSG00000176782), DEFB104B (ENSG00000177023), DEFB125 (ENSG00000178591), DEFB124 (ENSG00000180383), DEFB123 (ENSG00000180424), DEFB119 (ENSG00000180483), DEFB108B (ENSG00000184276), DEFB128 (ENSG00000185982), DEFB131A (ENSG00000186146), DEFB132 (ENSG00000186458), DEFB121 (ENSG00000204548), DEFB134 (ENSG00000205882), DEFB135 (ENSG00000205883), DEFB108C (ENSG00000215371), DEFB115 (ENSG00000215547), DEFB131B (ENSG00000225805)
Protein
Protein identifiers
Beta-defensin 116 — Q30KQ4 (reviewed: Q30KQ4)
Alternative names: Beta-defensin 16, Defensin, beta 116
All UniProt accessions (1): Q30KQ4
UniProt curated annotations — full annotation on UniProt →
Function. Has antibacterial activity.
Subcellular location. Secreted.
Similarity. Belongs to the beta-defensin family.
RefSeq proteins (1): NP_001032820* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR025933 | Beta_defensin_dom | Domain |
Pfam: PF13841
UniProt features (8 total): disulfide bond 3, signal peptide 1, chain 1, region of interest 1, compositionally biased region 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q30KQ4-F1 | 67.61 | 0.05 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (3): 40–67, 47–61, 51–68
Function
Pathways and Gene Ontology
Reactome pathways
2 pathways
| ID | Pathway |
|---|---|
| R-HSA-1461957 | Beta defensins |
| R-HSA-1461973 | Defensins |
MSigDB gene sets: 17 (showing top):
REACTOME_INNATE_IMMUNE_SYSTEM, GOBP_DEFENSE_RESPONSE_TO_OTHER_ORGANISM, chr20q11, GOBP_DEFENSE_RESPONSE_TO_BACTERIUM, GOBP_RESPONSE_TO_BACTERIUM, REACTOME_ANTIMICROBIAL_PEPTIDES, GOBP_BIOLOGICAL_PROCESS_INVOLVED_IN_INTERSPECIES_INTERACTION_BETWEEN_ORGANISMS, REACTOME_DEFENSINS, REACTOME_BETA_DEFENSINS, GSE2770_TGFB_AND_IL4_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN, GSE2585_CD80_HIGH_VS_LOW_MTEC_UP, GSE19888_ADENOSINE_A3R_INH_VS_ACT_WITH_INHIBITOR_PRETREATMENT_IN_MAST_CELL_DN, GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN, GSE22342_CD11C_HIGH_VS_LOW_DECIDUAL_MACROPHAGES_UP, GSE26030_TH1_VS_TH17_RESTIMULATED_DAY15_POST_POLARIZATION_UP
GO Biological Process (3): defense response to bacterium (GO:0042742), innate immune response (GO:0045087), defense response (GO:0006952)
GO Molecular Function (0):
GO Cellular Component (1): extracellular region (GO:0005576)
Reactome top-level categories
Rollup of top-2 pathways:
| Category | Pathways |
|---|---|
| Defensins | 1 |
| Antimicrobial peptides | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| defense response | 1 |
| response to bacterium | 1 |
| immune response | 1 |
| defense response to symbiont | 1 |
| response to stress | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
160 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DEFB116 | DEFB123 | Q8N688 | 672 |
| DEFB116 | DEFB125 | Q8N687 | 653 |
| DEFB116 | DEFB118 | Q96PH6 | 652 |
| DEFB116 | DEFB115 | Q30KQ5 | 632 |
| DEFB116 | DEFB127 | Q9H1M4 | 609 |
| DEFB116 | DEFB129 | Q9H1M3 | 578 |
| DEFB116 | DEFB128 | Q7Z7B8 | 561 |
| DEFB116 | DEFB126 | Q9BYW3 | 553 |
| DEFB116 | DEFB124 | Q8NES8 | 551 |
| DEFB116 | DEFB108B | Q8NET1 | 518 |
| DEFB116 | DEFB114 | Q30KQ6 | 507 |
| DEFB116 | DEFB121 | Q5J5C9 | 507 |
| DEFB116 | DEFB112 | Q30KQ8 | 426 |
| DEFB116 | DEFB107A | Q8IZN7 | 420 |
| DEFB116 | IL22RA2 | Q969J5 | 388 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DLG1 | DEFB116 | psi-mi:“MI:0407”(direct interaction) | 0.440 |
| DEFB116 | SRC | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (6): SYVN1 (Affinity Capture-MS), NCS1 (Affinity Capture-MS), SRC (Affinity Capture-MS), C11orf31 (Affinity Capture-MS), INSRR (Affinity Capture-MS), HS6ST3 (Affinity Capture-MS)
ESM2 similar proteins: A4H220, A4H221, A4H222, A4H223, A4H225, A4H227, A4H228, A4H238, A4H240, A4H253, A4H254, A4H255, A4H257, A4H258, A4H259, A4H262, A4H263, A4H264, A4H265, P0C8A8, P0DY26, P0DY27, Q29RT9, Q30KJ7, Q30KK0, Q30KK1, Q30KK9, Q30KL1, Q30KL7, Q30KP3, Q30KP5, Q30KQ4, Q30KQ5, Q30KQ8, Q30KR1, Q30KT5, Q32P86, Q32ZH2, Q32ZH6, Q3UW43
Diamond homologs: A4H225, A4H226, A4H227, A4H228, Q30KK6, Q30KK8, Q30KL1, Q30KQ4, Q30KT5, Q32P86, Q5J5C9, Q5J600, Q5J602, Q8K3I8, Q8N690, A4H235, A4H236, Q30KK5, Q5J5D0, Q5J5Z9, Q8K3U4, Q8N688, Q32ZG3, Q8BGW9, A4H211, A4H212, A4H213, A4H253, A4H254, A4H255, Q30KJ4, Q30KN8, Q30KP9, Q32ZG7, Q5IAB3, Q7Z7B8, Q8N104, A4H263, A4H264, A4H265
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
22 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
113 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 20:31303454:CTGGG:C | acceptor_loss | 0.9600 |
| 20:31303455:T:A | acceptor_loss | 0.9600 |
| 20:31303457:GGAAA:G | acceptor_loss | 0.9400 |
| 20:31303458:GAAAG:G | acceptor_loss | 0.9400 |
| 20:31303459:AAAGA:A | acceptor_loss | 0.9400 |
| 20:31303456:GGGAA:G | acceptor_loss | 0.9300 |
| 20:31308514:GTTA:G | donor_loss | 0.9200 |
| 20:31308515:TTA:T | donor_loss | 0.9200 |
| 20:31308516:TA:T | donor_loss | 0.9200 |
| 20:31308517:AC:A | donor_loss | 0.9200 |
| 20:31308518:C:CA | donor_loss | 0.9200 |
| 20:31308519:C:A | donor_loss | 0.9200 |
| 20:31303450:CCAC:C | acceptor_gain | 0.9000 |
| 20:31303451:CAC:C | acceptor_gain | 0.9000 |
| 20:31303451:CACC:C | acceptor_gain | 0.9000 |
| 20:31308513:AGTT:A | donor_loss | 0.9000 |
| 20:31303464:C:CT | acceptor_loss | 0.8900 |
| 20:31303465:A:T | acceptor_loss | 0.8700 |
| 20:31303454:C:CC | acceptor_gain | 0.8500 |
| 20:31303460:AAGAC:A | acceptor_loss | 0.8500 |
| 20:31303461:AGACA:A | acceptor_loss | 0.8500 |
| 20:31303463:A:C | acceptor_loss | 0.8100 |
| 20:31308266:C:CT | donor_gain | 0.8000 |
| 20:31308267:T:TT | donor_gain | 0.8000 |
| 20:31304345:T:TC | acceptor_gain | 0.7500 |
| 20:31303462:GACA:G | acceptor_loss | 0.7300 |
| 20:31303449:GCCAC:G | acceptor_gain | 0.7000 |
| 20:31303450:CCACC:C | acceptor_gain | 0.7000 |
| 20:31308520:T:A | donor_loss | 0.6500 |
| 20:31304987:T:TA | donor_gain | 0.6000 |
AlphaMissense
672 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 20:31303321:C:G | C67S | 0.943 |
| 20:31303322:A:T | C67S | 0.943 |
| 20:31303318:C:G | C68S | 0.942 |
| 20:31303319:A:T | C68S | 0.942 |
| 20:31303402:C:G | C40S | 0.942 |
| 20:31303403:A:T | C40S | 0.942 |
| 20:31303402:C:T | C40Y | 0.932 |
| 20:31303319:A:G | C68R | 0.927 |
| 20:31303322:A:G | C67R | 0.923 |
| 20:31303315:A:G | L69P | 0.918 |
| 20:31303403:A:G | C40R | 0.916 |
| 20:31303317:G:C | C68W | 0.913 |
| 20:31303381:C:G | C47S | 0.913 |
| 20:31303382:A:T | C47S | 0.913 |
| 20:31303320:G:C | C67W | 0.911 |
| 20:31303410:C:A | W37C | 0.908 |
| 20:31303410:C:G | W37C | 0.908 |
| 20:31303388:C:A | G45C | 0.906 |
| 20:31303402:C:A | C40F | 0.903 |
| 20:31303401:A:C | C40W | 0.900 |
| 20:31303369:C:G | C51S | 0.892 |
| 20:31303370:A:T | C51S | 0.892 |
| 20:31303370:A:G | C51R | 0.891 |
| 20:31303318:C:T | C68Y | 0.888 |
| 20:31303340:A:G | C61R | 0.886 |
| 20:31303369:C:T | C51Y | 0.885 |
| 20:31303357:T:A | E55V | 0.884 |
| 20:31303368:G:C | C51W | 0.884 |
| 20:31303388:C:G | G45R | 0.884 |
| 20:31303338:G:C | C61W | 0.868 |
dbSNP variants (sampled 300 via entrez): RS1000427464 (20:31303294 G>A,C), RS1000518031 (20:31307139 C>A), RS1000589831 (20:31306805 G>C), RS1001565391 (20:31309144 A>G), RS1002409104 (20:31305768 CT>C), RS1002419088 (20:31305561 G>GC), RS1002742885 (20:31307006 C>T), RS1002805649 (20:31304084 A>G), RS1002880510 (20:31303142 A>T), RS1002934338 (20:31309018 C>A,T), RS1004200078 (20:31310245 C>T), RS1004409203 (20:31305519 C>G,T), RS1004482217 (20:31305186 A>G,T), RS1004657108 (20:31310415 C>T), RS1004774689 (20:31305489 T>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004639_6 | Prudent dietary pattern | 2.000000e-06 |
| GCST007327_46 | Smoking status (ever vs never smokers) | 1.000000e-08 |
| GCST008810_51 | Smoking initiation (ever regular vs never regular) | 5.000000e-08 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008111 | diet measurement |
| EFO:0004318 | smoking behavior |
| EFO:0005670 | smoking initiation |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| CGP 52608 | affects binding, increases reaction | 1 |
| 2-palmitoylglycerol | increases expression | 1 |
| Benzo(a)pyrene | decreases methylation | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.